Developer docs
API playgroundTry for free, no card

Search company profiles

MNX Global Logistics

Full company profile

uuid0009gvd

Namestring
MNX Global Logistics
Legal namestring
MNX Global Logistics
Websiteurl
mnx.com
Company typeenum
Private
Founded yearint
1972
Descriptiontext

MNX Global Logistics was a US-based, private specialized expedited transportation and logistics provider founded in 1983 and headquartered in Irvine, United States, with 501–1000 employees. The company delivered precision logistics services to pharmaceutical, biotechnology, and healthcare customers, spanning health chain orchestration (drug storage and distribution), advanced therapy logistics (cell and gene therapies, biologics), connected medical device logistics, patient-driven services for decentralized clinical trials, laboratory specimen transport, complex secure logistics for controlled substances and radiopharmaceuticals, and clinical trial packaging. Operations were supported by a proprietary technology stack — Marken Apollo™ (warehouse management), Marken FastTrack™ (expedited shipment booking and tracking), Marken Maestro™ (clinical trial inventory and order management), Marken Solo™ (client portal), MxWeb and NetShip (client booking platforms), and Polar Track (temperature-monitored tracking) — combined with validated processes and regulatory oversight to meet healthcare and pharmaceutical compliance requirements.

The business model is enterprise B2B with quote-based pricing for specialized logistics services. Revenue is generated through service fees for temperature-controlled transport, clinical trial logistics, patient-driven services, and complex secure logistics for radiopharmaceuticals and advanced therapies, billed as professional services rather than transactional shipment fees. Distribution is direct, via enterprise field sales, account managers, and customer service specialists, with engagement channels including phone (+1-800-627-5361), online inquiry forms, and a multilingual (English, German, French, Spanish, Portuguese, Korean, Japanese, Chinese) website presence. The customer base is concentrated in two primary verticals — pharmaceutical and biotechnology companies — with healthcare providers and the home healthcare sector as secondary segments. Historically, MNX pursued inorganic growth, completing four acquisitions between 2016 and 2019 (Aero Express Logistics, Logical Freight Solutions, Network Global Logistics, and Global First) to extend aviation freight and global specialty logistics capabilities.

MNX has been acquired by Marken, a subsidiary of UPS, and the MNX brand has been retired; operations now continue as Marken, UPS Healthcare Precision Logistics. The integration brings MNX's expertise in radiopharmaceuticals, aviation, and complex secure logistics under the larger UPS Healthcare umbrella alongside Polar Speed's in-network pharmacy services. As an independent entity MNX is no longer operating under its original brand; standalone financials are no longer reported, and growth signals now flow through the parent Marken/UPS Healthcare platform.

Short descriptiontext

MNX Global Logistics (now Marken, UPS Healthcare Precision Logistics) provided specialized expedited transportation and logistics services — temperature-controlled transport, clinical trial logistics, advanced therapy handling, and complex secure logistics for radiopharmaceuticals — to pharmaceutical, biotechnology, and healthcare customers globally using a proprietary technology stack and validated, regulatory-compliant processes.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLong Beach, United States
HQ citystring
Long Beach
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare logistics services, cold chain transport, clinical trial logistics, pharmaceutical distribution, temperature-controlled shipping
Industry6 codes
PRIMARYHLAGAMAC
Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYTLAAAJAE
Clinical Trials & Investigational Product (IP) Cold Delivery
Transportation & Logistics/Courier, Express & Parcel (CEP) / Last-Mile Delivery/Cold-Chain Last-Mile Delivery (Refrigerated/Frozen)
SECONDARYTLAAAJAD
Biologics, Vaccines & Specialty Pharma Ultra-Cold Delivery
Transportation & Logistics/Courier, Express & Parcel (CEP) / Last-Mile Delivery/Cold-Chain Last-Mile Delivery (Refrigerated/Frozen)
SECONDARYTLAAAJAC
Pharmaceutical Cold-Chain Delivery (2–8°C / CRT)
Transportation & Logistics/Courier, Express & Parcel (CEP) / Last-Mile Delivery/Cold-Chain Last-Mile Delivery (Refrigerated/Frozen)
SECONDARYTLACAJAB
Pharmaceuticals & Life Sciences Forwarding (GxP/GDP)
Transportation & Logistics/Freight Forwarding & Customs Brokerage/Specialized Cargo Forwarding (Perishables/Pharma, Dangerous Goods, Live Animals)
SECONDARYTLAIAGAI
Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs)
NAICS code4 codes
  • Freight Transportation Arrangement488510
  • Couriers and Express Delivery Services492110
  • Refrigerated Warehousing and Storage493120
  • Specialized Freight Trucking4842
SIC code3 codes
  • Arrangement Of Transportation Of Freight & Cargo4731
  • Public Warehousing & Storage4220
  • Trucking (No Local)4213
Product category
Healthcare Logistics Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Logistics Services
TypeProfessional Services
Description

MNX (now Marken) generates revenue through providing specialized logistics services to pharmaceutical and biotech companies. Services include temperature-controlled transport, clinical trial logistics, patient-driven services, and complex secure logistics for radiopharmaceuticals and advanced therapies.

marken.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Infrastructure, Supply Chain, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MNX Global Logistics (now Marken, UPS Healthcare Precision Logistics) provides specialized, expedited transportation and logistics services for pharmaceutical, biotechnology, and healthcare clients. Its offering spans temperature-controlled cold chain transport, clinical trial material logistics, advanced therapy logistics for cell and gene therapies, direct-to-patient services, complex secure logistics for radiopharmaceuticals, and end-to-end drug storage and distribution from manufacturing to patient delivery.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Marken, UPS Healthcare Precision Logistics (formerly MNX Global Logistics) operates as a unified platform-plus-modules architecture providing end-to-end healthcare logistics services. The portfolio comprises nine core service lines—Health Chain Orchestration, Advanced Therapy Logistics, Connected Medical Device Logistics & Management, Patient Driven Services, Laboratory Advantage, Complex Secure Logistics, Packaging as a Service, Technology & Visibility, and Polar Speed Services—supported by six technology platforms: Marken Apollo™ (warehouse management), Marken FastTrack™ (expedited shipment booking), Marken Maestro™ (inventory management), Marken Solo™ (client portal), MxWeb (web-based client portal), NetShip (online shipping), and Polar Track (temperature-monitored tracking). The platform leverages validated processes, regulatory oversight, and global network infrastructure to serve pharmaceutical, biotechnology, and healthcare clients across all phases from manufacturing to patient delivery.

Product and service8 records
1Health Chain Orchestration
CategoryHealthcare Logistics Services
Description

End-to-end drug storage and distribution service managing the complete healthcare supply chain from manufacturing to patient delivery for pharmaceutical clients.

2Advanced Therapy Logistics
CategoryHealthcare Logistics Services
Description

Specialized logistics for complex biologics, cell therapies, and gene therapies requiring precise temperature control and chain of custody, targeting biotechnology and pharmaceutical clients.

3Connected Medical Device Logistics & Management
CategoryHealthcare Logistics Services
Description

Integrated logistics and management solutions for medical devices with tracking and visibility throughout the distribution process, serving medical device manufacturers.

4Patient Driven Services
CategoryClinical Trial Logistics
Description

Decentralized clinical trial services that deliver investigational drugs directly to patients, supporting home healthcare and distributed trial models for clinical trial sponsors and home healthcare providers.

5Laboratory Advantage
CategoryHealthcare Logistics Services
Description

Specialized laboratory logistics services including specimen transport, bio-specimen handling, and sample management for clinical and research laboratories.

6Complex Secure Logistics
CategoryHealthcare Logistics Services
Description

High-security logistics for controlled substances, radiopharmaceuticals, and other sensitive materials requiring enhanced chain of custody, serving pharmaceutical and biotech clients.

7Packaging as a Service
CategoryClinical Trial Logistics
Description

Clinical trial packaging services providing temperature-controlled packaging solutions for pharmaceutical shipments.

8Polar Speed Services
CategoryClinical Trial Logistics
Description

In-network pharmacy services that strengthen the patient-driven services portfolio, providing temperature-controlled medication delivery for home healthcare and clinical trial patients.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1UPS Healthcare
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

MNX Global Logistics has been acquired by UPS Healthcare and now operates under the Marken brand as 'Marken, UPS Healthcare Precision Logistics'. The acquisition brought MNX's specialized expertise in radiopharmaceuticals, aviation, and complex secure logistics under the UPS Healthcare umbrella, combining decades of experience with UPS's global infrastructure and technology investments.

marken.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

World Courier (an AmerisourceBergen company) is the leading specialty pharma and clinical trial logistics provider globally, offering temperature-controlled transport, advanced therapy logistics, and direct-to-patient services—directly overlapping MNX/Marken's core offering.

TypeBroad incumbent
Description

Cardinal Health's third-party logistics services include medical product distribution, cold-chain storage, and pharmaceutical supply chain management—overlapping with MNX/Marken's health chain orchestration and medical device logistics offerings.

TypeEmerging player
Description

Cryoport provides integrated temperature-controlled supply chain solutions for the life sciences industry with strong focus on regenerative medicine, cell and gene therapies—directly competing with MNX/Marken's advanced therapy logistics.

TypeDirect peer
Description

Biocair is a specialist life sciences logistics provider focused on temperature-controlled pharma, clinical trial, and advanced therapy shipments across global lanes, directly comparable to MNX's specialty courier offering.

5FedEx Custom Critical
TypeBroad incumbent
Description

FedEx Custom Critical provides time-critical, temperature-sensitive, and high-value shipment services including pharma and healthcare—overlapping with MNX's expedited and radiopharmaceutical services as part of a broader logistics portfolio.

TypeBroad incumbent
Description

DHL Supply Chain's Life Sciences division provides contract logistics, warehousing, and transportation for pharma and medical devices—overlapping with MNX/Marken's warehousing and health chain orchestration services.

TypeDirect peer
Description

QuickSTAT specializes in global clinical trial logistics, biopharmaceutical courier services, and direct-to-patient delivery—directly competing with MNX/Marken in investigator-site and patient-centric services.

TypeDirect peer
Description

DHL Medical Express provides global time-critical, temperature-controlled pharmaceutical shipments with comparable GxP/GDP compliance, serving the same enterprise pharma and biotech customer base as MNX/Marken.

9Yusen Logistics (Healthcare)
TypeBroad incumbent
Description

Yusen Logistics provides GDP-compliant healthcare logistics including temperature-controlled transport, warehousing, and clinical trial distribution across Asia, Europe, and the Americas—competing with MNX/Marken on global pharma lanes.

TypeBroad incumbent
Description

Kuehne+Nagel's Life Sciences & Healthcare division offers GxP-compliant pharma logistics, cold chain, and clinical trial services globally—competing with MNX/Marken across multiple service lines with broader scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MNX Global Logistics

Healthcare Logistics Servicesmnx.com

MNX Global Logistics (now Marken, UPS Healthcare Precision Logistics) provided specialized expedited transportation and logistics services — temperature-controlled transport, clinical trial logistics, advanced therapy handling, and complex secure logistics for radiopharmaceuticals — to pharmaceutical, biotechnology, and healthcare customers globally using a proprietary technology stack and validated, regulatory-compliant processes.

What MNX Global Logistics does

MNX Global Logistics was a US-based, private specialized expedited transportation and logistics provider founded in 1983 and headquartered in Irvine, United States, with 501–1000 employees. The company delivered precision logistics services to pharmaceutical, biotechnology, and healthcare customers, spanning health chain orchestration (drug storage and distribution), advanced therapy logistics (cell and gene therapies, biologics), connected medical device logistics, patient-driven services for decentralized clinical trials, laboratory specimen transport, complex secure logistics for controlled substances and radiopharmaceuticals, and clinical trial packaging. Operations were supported by a proprietary technology stack — Marken Apollo™ (warehouse management), Marken FastTrack™ (expedited shipment booking and tracking), Marken Maestro™ (clinical trial inventory and order management), Marken Solo™ (client portal), MxWeb and NetShip (client booking platforms), and Polar Track (temperature-monitored tracking) — combined with validated processes and regulatory oversight to meet healthcare and pharmaceutical compliance requirements.

The business model is enterprise B2B with quote-based pricing for specialized logistics services. Revenue is generated through service fees for temperature-controlled transport, clinical trial logistics, patient-driven services, and complex secure logistics for radiopharmaceuticals and advanced therapies, billed as professional services rather than transactional shipment fees. Distribution is direct, via enterprise field sales, account managers, and customer service specialists, with engagement channels including phone (+1-800-627-5361), online inquiry forms, and a multilingual (English, German, French, Spanish, Portuguese, Korean, Japanese, Chinese) website presence. The customer base is concentrated in two primary verticals — pharmaceutical and biotechnology companies — with healthcare providers and the home healthcare sector as secondary segments. Historically, MNX pursued inorganic growth, completing four acquisitions between 2016 and 2019 (Aero Express Logistics, Logical Freight Solutions, Network Global Logistics, and Global First) to extend aviation freight and global specialty logistics capabilities.

MNX has been acquired by Marken, a subsidiary of UPS, and the MNX brand has been retired; operations now continue as Marken, UPS Healthcare Precision Logistics. The integration brings MNX's expertise in radiopharmaceuticals, aviation, and complex secure logistics under the larger UPS Healthcare umbrella alongside Polar Speed's in-network pharmacy services. As an independent entity MNX is no longer operating under its original brand; standalone financials are no longer reported, and growth signals now flow through the parent Marken/UPS Healthcare platform.

MNX Global Logistics firmographics

Firmographics
Name
MNX Global Logistics
Legal name
MNX Global Logistics
Website
https://mnx.com
Company type
Private
Founded year
1972
Operating status
Acquired
Headcount range
251–500 employees
Short description
MNX Global Logistics (now Marken, UPS Healthcare Precision Logistics) provided specialized expedited transportation and logistics services — temperature-controlled transport, clinical trial logistics, advanced therapy handling, and complex secure logistics for radiopharmaceuticals — to pharmaceutical, biotechnology, and healthcare customers globally using a proprietary technology stack and validated, regulatory-compliant processes.
Ownership category
akta.pro rank

MNX Global Logistics industry classification

Industry
Product category
Healthcare Logistics Services
NAICS
Freight Transportation Arrangement (488510), Couriers and Express Delivery Services (492110), Refrigerated Warehousing and Storage (493120), Specialized Freight Trucking (4842)
SIC
Arrangement Of Transportation Of Freight & Cargo (4731), Public Warehousing & Storage (4220), Trucking (No Local) (4213)
akta.pro industry
PRIMARYHLAGAMAC
Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYTLAAAJAE
Clinical Trials & Investigational Product (IP) Cold Delivery
Transportation & Logistics/Courier, Express & Parcel (CEP) / Last-Mile Delivery/Cold-Chain Last-Mile Delivery (Refrigerated/Frozen)
SECONDARYTLAAAJAD
Biologics, Vaccines & Specialty Pharma Ultra-Cold Delivery
Transportation & Logistics/Courier, Express & Parcel (CEP) / Last-Mile Delivery/Cold-Chain Last-Mile Delivery (Refrigerated/Frozen)
SECONDARYTLAAAJAC
Pharmaceutical Cold-Chain Delivery (2–8°C / CRT)
Transportation & Logistics/Courier, Express & Parcel (CEP) / Last-Mile Delivery/Cold-Chain Last-Mile Delivery (Refrigerated/Frozen)
SECONDARYTLACAJAB
Pharmaceuticals & Life Sciences Forwarding (GxP/GDP)
Transportation & Logistics/Freight Forwarding & Customs Brokerage/Specialized Cargo Forwarding (Perishables/Pharma, Dangerous Goods, Live Animals)
SECONDARYTLAIAGAI
Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs)

Keywords

  • Healthcare logistics services
  • Cold chain transport
  • Clinical trial logistics
  • Pharmaceutical distribution
  • Temperature-controlled shipping

Where MNX Global Logistics is headquartered

Location

Headquarters

HQ city
Long Beach
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MNX Global Logistics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Personnel, Infrastructure, Supply Chain, Technology or R&D

Revenue model

  1. Healthcare Logistics Services: MNX (now Marken) generates revenue through providing specialized logistics services to pharmaceutical and biotech companies. Services include temperature-controlled transport, clinical trial logistics, patient-driven services, and complex secure logistics for radiopharmaceuticals and advanced therapies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

MNX Global Logistics product offering

Product offering

Core offering

MNX Global Logistics (now Marken, UPS Healthcare Precision Logistics) provides specialized, expedited transportation and logistics services for pharmaceutical, biotechnology, and healthcare clients. Its offering spans temperature-controlled cold chain transport, clinical trial material logistics, advanced therapy logistics for cell and gene therapies, direct-to-patient services, complex secure logistics for radiopharmaceuticals, and end-to-end drug storage and distribution from manufacturing to patient delivery.

Product overview

Marken, UPS Healthcare Precision Logistics (formerly MNX Global Logistics) operates as a unified platform-plus-modules architecture providing end-to-end healthcare logistics services. The portfolio comprises nine core service lines—Health Chain Orchestration, Advanced Therapy Logistics, Connected Medical Device Logistics & Management, Patient Driven Services, Laboratory Advantage, Complex Secure Logistics, Packaging as a Service, Technology & Visibility, and Polar Speed Services—supported by six technology platforms: Marken Apollo™ (warehouse management), Marken FastTrack™ (expedited shipment booking), Marken Maestro™ (inventory management), Marken Solo™ (client portal), MxWeb (web-based client portal), NetShip (online shipping), and Polar Track (temperature-monitored tracking). The platform leverages validated processes, regulatory oversight, and global network infrastructure to serve pharmaceutical, biotechnology, and healthcare clients across all phases from manufacturing to patient delivery.

Differentiator

Problem solved

Functional benefit

Products and services

  • Health Chain Orchestration End-to-end drug storage and distribution service managing the complete healthcare supply chain from manufacturing to patient delivery for pharmaceutical clients.
  • Advanced Therapy Logistics Specialized logistics for complex biologics, cell therapies, and gene therapies requiring precise temperature control and chain of custody, targeting biotechnology and pharmaceutical clients.
  • Connected Medical Device Logistics & Management Integrated logistics and management solutions for medical devices with tracking and visibility throughout the distribution process, serving medical device manufacturers.
  • Patient Driven Services Decentralized clinical trial services that deliver investigational drugs directly to patients, supporting home healthcare and distributed trial models for clinical trial sponsors and home healthcare providers.
  • Laboratory Advantage Specialized laboratory logistics services including specimen transport, bio-specimen handling, and sample management for clinical and research laboratories.
  • Complex Secure Logistics High-security logistics for controlled substances, radiopharmaceuticals, and other sensitive materials requiring enhanced chain of custody, serving pharmaceutical and biotech clients.
  • Packaging as a Service Clinical trial packaging services providing temperature-controlled packaging solutions for pharmaceutical shipments.
  • Polar Speed Services In-network pharmacy services that strengthen the patient-driven services portfolio, providing temperature-controlled medication delivery for home healthcare and clinical trial patients.

Companies that use MNX Global Logistics

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

MNX Global Logistics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

MNX Global Logistics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • UPS HealthcarecoreOEM/ Whitelabel/ Licensing PartnerMNX Global Logistics has been acquired by UPS Healthcare and now operates under the Marken brand as 'Marken, UPS Healthcare Precision Logistics'. The acquisition brought MNX's specialized expertise in radiopharmaceuticals, aviation, and complex secure logistics under the UPS Healthcare umbrella, combining decades of experience with UPS's global infrastructure and technology investments.

Scale indicators2 records

Recent moves7 records

Expansion highlights4 records

MNX Global Logistics competitors and assessment

Company assessment

Direct peers

  • World Courier: World Courier (an AmerisourceBergen company) is the leading specialty pharma and clinical trial logistics provider globally, offering temperature-controlled transport, advanced therapy logistics, and direct-to-patient services—directly overlapping MNX/Marken's core offering.
  • Biocair: Biocair is a specialist life sciences logistics provider focused on temperature-controlled pharma, clinical trial, and advanced therapy shipments across global lanes, directly comparable to MNX's specialty courier offering.
  • QuickSTAT: QuickSTAT specializes in global clinical trial logistics, biopharmaceutical courier services, and direct-to-patient delivery—directly competing with MNX/Marken in investigator-site and patient-centric services.
  • DHL Medical Express: DHL Medical Express provides global time-critical, temperature-controlled pharmaceutical shipments with comparable GxP/GDP compliance, serving the same enterprise pharma and biotech customer base as MNX/Marken.

Broad incumbents

  • Cardinal Health 3PL Services: Cardinal Health's third-party logistics services include medical product distribution, cold-chain storage, and pharmaceutical supply chain management—overlapping with MNX/Marken's health chain orchestration and medical device logistics offerings.
  • FedEx Custom Critical: FedEx Custom Critical provides time-critical, temperature-sensitive, and high-value shipment services including pharma and healthcare—overlapping with MNX's expedited and radiopharmaceutical services as part of a broader logistics portfolio.
  • DHL Supply Chain Life Sciences: DHL Supply Chain's Life Sciences division provides contract logistics, warehousing, and transportation for pharma and medical devices—overlapping with MNX/Marken's warehousing and health chain orchestration services.
  • Yusen Logistics (Healthcare): Yusen Logistics provides GDP-compliant healthcare logistics including temperature-controlled transport, warehousing, and clinical trial distribution across Asia, Europe, and the Americas—competing with MNX/Marken on global pharma lanes.
  • Kuehne+Nagel Life Sciences & Healthcare: Kuehne+Nagel's Life Sciences & Healthcare division offers GxP-compliant pharma logistics, cold chain, and clinical trial services globally—competing with MNX/Marken across multiple service lines with broader scale.

Emerging players

  • Cryoport Systems: Cryoport provides integrated temperature-controlled supply chain solutions for the life sciences industry with strong focus on regenerative medicine, cell and gene therapies—directly competing with MNX/Marken's advanced therapy logistics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

MNX Global Logistics social profiles

Digital presence

MNX Global Logistics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MNX Global Logistics leadership team

Management profile

Number of profiles

Profiles2 records

MNX Global Logistics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MNX Global Logistics M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MNX Global Logistics

What does MNX Global Logistics do?

MNX Global Logistics (now Marken, UPS Healthcare Precision Logistics) provides specialized, expedited transportation and logistics services for pharmaceutical, biotechnology, and healthcare clients. Its offering spans temperature-controlled cold chain transport, clinical trial material logistics, advanced therapy logistics for cell and gene therapies, direct-to-patient services, complex secure logistics for radiopharmaceuticals, and end-to-end drug storage and distribution from manufacturing to patient delivery.

Is MNX Global Logistics a public or private company?

MNX Global Logistics is a private company. It is classified as corporate owned and is currently acquired.

When was MNX Global Logistics founded?

MNX Global Logistics was founded in 1972. It employs 251 to 500 people.

Where is MNX Global Logistics based?

MNX Global Logistics is headquartered in Long Beach, United States, in the North America region.

How does MNX Global Logistics make money?

One revenue line is on record: healthcare Logistics Services.

Who are MNX Global Logistics's main competitors?

Direct peers on record are World Courier, Biocair, QuickSTAT and DHL Medical Express. Broad incumbents are Cardinal Health 3PL Services, FedEx Custom Critical, DHL Supply Chain Life Sciences, Yusen Logistics (Healthcare) and Kuehne+Nagel Life Sciences & Healthcare. Cryoport Systems is listed as an emerging player.

Does MNX Global Logistics have an API?

No public API is recorded for MNX Global Logistics.

What industry is MNX Global Logistics in?

MNX Global Logistics's product category is Healthcare Logistics Services. Its primary akta.pro industry code is HLAGAMAC, Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns), with a secondary code of TLAAAJAE, Clinical Trials & Investigational Product (IP) Cold Delivery. Its NAICS code is 488510 and its SIC code is 4731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ReutersUPS targets lucrative e-commerce returns, healthcare with acquisitionsUPS announced an agreement to acquire Happy Returns from PayPal, a month after signaling intent to buy MNX Global Logistics. The deal amounts were not disclosed, but UPS expects its e-commerce returns business to grow 25% since 2020. The acquisitions aim to boost high-margin healthcare and e-commerce returns operations.BenzingaWall Street's Most Accurate Analysts Say Hold These 3 Industrials Stocks With Over 3% Dividend Yields - KBenzinga reported analyst ratings from the most accurate Wall Street analysts covering three high-yield dividend stocks in the industrials sector: Paychex, Kennametal, and United Parcel Service (UPS). Morgan Stanley raised its price target on Paychex to $127 while noting better-than-expected Q1 earnings, Barclays raised Kennametal's target to $28 ahead of its earnings call, and JP Morgan lowered UPS's target to $178. UPS separately announced the acquisition of MNX Global Logistics for an undisclosed amount.Pulse 2.0Why UPS Is Buying Logistics Provider MNXUPS agreed to acquire MNX Global Logistics, a global time-critical logistics provider, to enhance healthcare and temperature-controlled services. The deal is expected to close by year-end, subject to regulatory review, with terms undisclosed.FinSMEsUPS to Acquire MNXUPS acquired MNX, a time-critical logistics provider, with the deal expected to close by year-end subject to regulatory review. The value and terms were not disclosed. The acquisition will expand UPS Healthcare's time-sensitive logistics capabilities, including radio-pharmaceuticals and temperature-controlled services.PYMNTS.comUPS Acquires MNX to Enhance Time-Critical Logistics for HealthcareUPS agreed to acquire MNX Global Logistics, a global time-critical logistics provider, to enhance its healthcare and related industries logistics. The deal, expected to close by year-end pending regulatory review, will complement UPS Healthcare and Marken. The value and terms were not disclosed.Business Wire BlogUPS to Acquire MNX in Strategic Move to Expand Global Healthcare and Time-Critical CapabilitiesUPS announced an agreement to acquire MNX Global Logistics, a global time-critical logistics provider, to expand its healthcare and time-sensitive capabilities. The deal is expected to close by year-end, subject to regulatory review, with terms undisclosed. MNX's radio-pharmaceuticals and temperature-controlled services will support UPS Healthcare and Marken.Cognitive Market ResearchThe global Logistics market size will be USD 10254.5 million in 2024.Cognitive Market Research published a report projecting the global logistics market size to reach USD 10,254.5 million in 2024, with forecasts indicating expansion through 2034 driven by e-commerce and globalization. The report highlights North America as the dominant region holding over 40% of global revenue, while Asia Pacific is identified as the fastest-growing segment. Key industry developments cited include A.P. Moller-Maersk's new air freight gateway in Miami and United Parcel Service's acquisition of MNX Global Logistics.PR NewswireQuad-C Management Completes Recapitalization of MNX Global LogisticsQuad-C Management has completed the recapitalization of MNX Global Logistics, acquiring the business from Audax Private Equity. MNX will remain led by its current President and CEO, John Labrie, as it pursues growth initiatives and strategic acquisitions in the time-critical logistics sector. The financial terms of this transaction were not disclosed.Business Wire BlogMNX Global Logistics and WebOps Collaborate to Offer Medical Device Manufacturers and Distributors White Glove Inside Delivery, Asset Visibility and Inventory ManagementMNX Global Logistics and WebOps LLC announced a collaboration to offer medical device manufacturers and distributors end-to-end solutions for case-level surgical kits, including transportation, final-mile inside deliveries, and inventory management. The partnership combines MNX's precision logistics platform with WebOps' software to streamline order initiation, asset tracking, and inventory visibility.